These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23728588)

  • 41. The time is crucial for ex vivo expansion of T regulatory cells for therapy.
    Marek N; Bieniaszewska M; Krzystyniak A; Juścińska J; Myśliwska J; Witkowski P; Hellmann A; Trzonkowski P
    Cell Transplant; 2011; 20(11-12):1747-58. PubMed ID: 21457615
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
    Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD127(low/-) and FoxP3(+) expression levels characterize different regulatory T-cell populations in human peripheral blood.
    Klein S; Kretz CC; Krammer PH; Kuhn A
    J Invest Dermatol; 2010 Feb; 130(2):492-9. PubMed ID: 19940860
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer.
    Yokokawa J; Cereda V; Remondo C; Gulley JL; Arlen PM; Schlom J; Tsang KY
    Clin Cancer Res; 2008 Feb; 14(4):1032-40. PubMed ID: 18281535
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapamycin combined with allogenic immature dendritic cells selectively expands CD4+CD25+Foxp3+ regulatory T cells in rats.
    Wang GY; Zhang Q; Yang Y; Chen WJ; Liu W; Jiang N; Chen GH
    Hepatobiliary Pancreat Dis Int; 2012 Apr; 11(2):203-8. PubMed ID: 22484590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elevated frequencies of CD4⁺ CD25⁺ CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia.
    Shenghui Z; Yixiang H; Jianbo W; Kang Y; Laixi B; Yan Z; Xi X
    Int J Cancer; 2011 Sep; 129(6):1373-81. PubMed ID: 21105040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulatory T cells in the pathogenesis and healing of chronic human dermal leishmaniasis caused by Leishmania (Viannia) species.
    Rodriguez-Pinto D; Navas A; Blanco VM; Ramírez L; Garcerant D; Cruz A; Craft N; Saravia NG
    PLoS Negl Trop Dis; 2012; 6(4):e1627. PubMed ID: 22545172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells?
    Yang HX; Zhang W; Zhao LD; Li Y; Zhang FC; Tang FL; He W; Zhang X
    Arthritis Res Ther; 2009; 11(5):R153. PubMed ID: 19821980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination.
    Vergati M; Cereda V; Madan RA; Gulley JL; Huen NY; Rogers CJ; Hance KW; Arlen PM; Schlom J; Tsang KY
    Cancer Immunol Immunother; 2011 Feb; 60(2):197-206. PubMed ID: 20976449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Higher frequency of regulatory T cells in granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts compared with G-CSF-primed peripheral blood grafts.
    Zhao XY; Wang YT; Mo XD; Zhao XS; Wang YZ; Chang YJ; Huang XJ
    J Transl Med; 2015 May; 13():145. PubMed ID: 25948100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunity.
    Tran GT; Hodgkinson SJ; Carter NM; Verma ND; Plain KM; Boyd R; Robinson CM; Nomura M; Killingsworth M; Hall BM
    Blood; 2012 May; 119(19):4441-50. PubMed ID: 22310911
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
    Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
    Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Percentage and function of CD4+CD25+ regulatory T cells in patients with hyperthyroidism.
    Jiang TJ; Cao XL; Luan S; Cui WH; Qiu SH; Wang YC; Zhao CJ; Fu P
    Mol Med Rep; 2018 Feb; 17(2):2137-2144. PubMed ID: 29207121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
    Bocian K; Borysowski J; Wierzbicki P; Wyzgal J; Klosowska D; Bialoszewska A; Paczek L; Górski A; Korczak-Kowalska G
    Nephrol Dial Transplant; 2010 Mar; 25(3):710-7. PubMed ID: 19903662
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
    Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
    Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Temporal and spatial characterization of negative regulatory T cells in HIV-infected/AIDS patients raises new diagnostic markers and therapeutic strategies.
    Chen H; Ren C; Song H; Ma LL; Chen SF; Wu MJ; Zhang H; Xu JC; Xu P
    J Clin Lab Anal; 2021 Jul; 35(7):e23831. PubMed ID: 34028085
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Telbivudine decreases proportion of peripheral blood CD4+CD25+CD127low T cells in parallel with inhibiting hepatitis B virus DNA.
    Yan Z; Zhou J; Zhang M; Fu X; Wu Y; Wang Y
    Mol Med Rep; 2014 May; 9(5):2024-30. PubMed ID: 24626572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of CD4⁺CD25⁺FOXP3⁺ regulatory T cells is associated with resistance to intravenous immunoglobulin therapy in patients with Kawasaki disease.
    Hirabayashi Y; Takahashi Y; Xu Y; Akane K; Villalobos IB; Okuno Y; Hasegawa S; Muramatsu H; Hama A; Kato T; Kojima S
    Eur J Pediatr; 2013 Jun; 172(6):833-7. PubMed ID: 23340699
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outgrowth of CD4low/negCD25+ T cells with suppressor function in CD4+CD25+ T cell cultures upon polyclonal stimulation ex vivo.
    Vogtenhuber C; O'Shaughnessy MJ; Vignali DA; Blazar BR
    J Immunol; 2008 Dec; 181(12):8767-75. PubMed ID: 19050298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.